ARQT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 9.50%

Insider Buying (Last 12 Months): $7,771.23

Insider Selling (Last 12 Months): $2,446,083.42

Arcutis Biotherapeutics Insider Trading History Chart

Arcutis Biotherapeutics Share Price & Price History

^$13.53

▲ +0.52 (4.00%)

As of 04/21/2025 05:00 PM ET

Days: 30 | 90 | 365

Arcutis Biotherapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/24/2025	Todd Franklin Watanabe	Insider	Sell	1,500	$17.52	$26,280.00	927,414
3/17/2025	Todd Franklin Watanabe	Insider	Sell	1,200	$17.61	$21,132.00	928,914
3/14/2025	Patrick Burnett	Insider	Sell	12,242	$15.04	$184,119.68	121,936
3/3/2025	Howard G. Welgus	Director	Sell	10,000	$13.00	$130,000.00	131,944
3/3/2025	Patrick Burnett	Insider	Sell	2,819	$13.03	$36,731.57	167,043
2/3/2025	Howard G. Welgus	Director	Sell	10,000	$12.71	$127,100.00	141,944
2/3/2025	Masaru Matsuda	Insider	Sell	8,338	$12.70	$105,892.60	178,692
1/2/2025	Howard G. Welgus	Director	Sell	10,000	$14.67	$146,700.00	151,944
12/31/2024	Patrick Burnett	Insider	Sell	1,691	$14.00	$23,674.00	126,978
12/20/2024	Todd Franklin Watanabe	Insider	Sell	15,000	$15.17	$227,550.00	823,430
12/2/2024	Howard G. Welgus	Director	Sell	10,000	$12.51	$125,100.00	161,944
11/30/2024	Larry Todd Edwards	Insider	Buy	1,093	$7.11	$7,771.23	137,728
11/22/2024	Patrick Burnett	Insider	Sell	16,023	$10.14	$162,473.22	128,669
11/19/2024	Masaru Matsuda	Insider	Sell	1,775	$9.68	$17,182.00	181,373
11/15/2024	Patrick Burnett	Insider	Sell	100	$10.03	$1,003.00	128,669
11/11/2024	Terrie Curran	Director	Sell	8,687	$10.85	$94,253.95	10,139
11/4/2024	Masaru Matsuda	Insider	Sell	5,015	$8.68	$43,530.20	178,273
11/1/2024	Howard G. Welgus	Director	Sell	10,000	$8.65	$86,500.00	171,944
10/2/2024	Larry Todd Edwards	SVP	Sell	3,725	$10.01	$37,287.25	136,635
10/1/2024	Howard G. Welgus	Director	Sell	10,000	$9.26	$92,600.00	181,944
9/24/2024	David Joseph Topper	CFO	Sell	11,626	$9.48	$110,214.48	158,374
9/3/2024	Howard G. Welgus	Director	Sell	10,000	$10.77	$107,700.00	191,944
8/19/2024	Patrick Burnett	Insider	Sell	1,728	$8.29	$14,325.12	194,859
8/2/2024	Masaru Matsuda	Insider	Sell	5,220	$9.02	$47,084.40	183,288
8/1/2024	Howard G. Welgus	Director	Sell	10,000	$9.87	$98,700.00	176,953
7/1/2024	Howard G. Welgus	Director	Sell	10,000	$9.31	$93,100.00	180,339
5/30/2024	Patrick Burnett	Insider	Sell	23,000	$8.75	$201,250.00	209,793
5/28/2024	Masaru Matsuda	Insider	Sell	1,775	$9.01	$15,992.75	188,508
5/17/2024	Larry Todd Edwards	SVP	Sell	7,640	$8.98	$68,607.20	140,360
3/4/2024	Masaru Matsuda	Insider	Sell	3,760	$11.12	$41,811.20	190,424
1/2/2024	Patrick Burnett	Insider	Sell	1,325	$3.54	$4,690.50	57,032
11/21/2023	Masaru Matsuda	Insider	Sell	1,850	$1.98	$3,663.00	46,634
10/24/2023	Life Sciences Viii L Frazier	Major Shareholder	Buy	80,000	$2.50	$200,000.00	8,764,232
8/21/2023	Patrick Burnett	Insider	Sell	1,605	$7.04	$11,299.20	58,357
5/31/2023	Masaru Matsuda	Insider	Sell	1,830	$7.80	$14,274.00	42,146
4/17/2023	Howard G. Welgus	Director	Sell	8,500	$13.97	$118,745.00	165,825
4/6/2023	Howard G. Welgus	Director	Sell	8,500	$12.01	$102,085.00	165,825
3/6/2023	Patricia A. Turney	SVP	Sell	831	$15.26	$12,681.06	62,862
3/6/2023	Scott L. Burrows	CFO	Sell	291	$15.26	$4,440.66	59,115
3/6/2023	Todd Franklin Watanabe	Insider	Sell	2,435	$15.26	$37,158.10	366,657
3/2/2023	Patricia A. Turney	SVP	Sell	1,432	$15.83	$22,668.56	45,693
3/2/2023	Scott L. Burrows	CFO	Sell	1,434	$15.83	$22,700.22	38,406
3/2/2023	Todd Franklin Watanabe	Insider	Sell	5,472	$15.83	$86,621.76	369,092
2/28/2023	Patricia A. Turney	SVP	Sell	936	$16.17	$15,135.12	47,125
2/28/2023	Scott L. Burrows	CFO	Sell	416	$16.17	$6,726.72	39,840
2/28/2023	Todd Franklin Watanabe	Insider	Sell	2,343	$16.17	$37,886.31	374,564
2/15/2023	Howard G. Welgus	Director	Sell	8,500	$16.98	$144,330.00	165,825
2/13/2023	Todd Franklin Watanabe	Insider	Sell	483	$17.00	$8,211.00	377,424
1/17/2023	Howard G. Welgus	Director	Sell	8,500	$13.72	$116,620.00	165,825
1/3/2023	Patrick Burnett	Insider	Sell	1,475	$15.01	$22,139.75	41,564
12/7/2022	Todd Franklin Watanabe	Insider	Sell	1,000	$17.06	$17,060.00	378,907
11/21/2022	Masaru Matsuda	Insider	Sell	1,720	$18.19	$31,286.80	19,535
11/7/2022	Todd Franklin Watanabe	Insider	Sell	1,000	$18.00	$18,000.00	379,907
10/7/2022	Todd Franklin Watanabe	CEO	Sell	1,000	$19.51	$19,510.00	380,907
10/4/2022	Howard G. Welgus	Director	Sell	6,000	$20.29	$121,740.00	168,208
9/7/2022	Todd Franklin Watanabe	CEO	Sell	1,000	$21.51	$21,510.00	381,907
8/15/2022	Howard G. Welgus	Director	Sell	6,000	$24.80	$148,800.00	174,208
7/18/2022	Howard G. Welgus	Director	Sell	6,000	$24.40	$146,400.00	180,208
7/8/2022	David W Osborne	Insider	Sell	2,197	$25.41	$55,825.77	256,649
7/8/2022	Todd Franklin Watanabe	CEO	Sell	13,500	$25.37	$342,495.00	651,871
7/6/2022	Todd Franklin Watanabe	CEO	Sell	1,000	$22.07	$22,070.00	658,284
6/24/2022	Orbimed Advisors Llc	Major Shareholder	Sell	341,971	$21.31	$7,287,402.01	415,142
6/2/2022	Masaru Matsuda	SVP	Sell	1,795	$19.73	$35,415.35	16,380
6/1/2022	Howard G. Welgus	Director	Sell	2,500	$20.62	$51,550.00	181,896
5/5/2022	Todd Franklin Watanabe	CEO	Sell	1,000	$21.76	$21,760.00	658,667
5/2/2022	Howard G. Welgus	Director	Sell	2,500	$20.44	$51,100.00	181,896

See Full Table

SEC Filings (Institutional Ownership Changes) for Arcutis Biotherapeutics (NASDAQ:ARQT)

Institutional Buying and Selling by Quarter

Arcutis Biotherapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/21/2025	Silverleafe Capital Partners LLC	26,208	$0.41M	0.1%	N/A	0.022%
4/15/2025	SG Americas Securities LLC	32,566	$0.51M	0.0%	-32.3%	0.027%
4/9/2025	LVW Advisors LLC	14,466	$0.23M	0.0%	+21.2%	0.012%
4/8/2025	Rhumbline Advisers	181,074	$2.83M	0.0%	+7.7%	0.153%
4/7/2025	GAMMA Investing LLC	15,515	$2.43M	0.0%	+1,261.0%	0.013%
3/24/2025	Wellington Management Group LLP	49,267	$0.69M	0.0%	-7.3%	0.042%
3/17/2025	Wealth Enhancement Advisory Services LLC	20,912	$0.29M	0.0%	N/A	0.018%
2/27/2025	Jefferies Financial Group Inc.	109,900	$1.53M	0.0%	-14.3%	0.094%
2/19/2025	GF Fund Management CO. LTD.	2,458	$34K	0.0%	N/A	0.002%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	280,100	$3.90M	0.0%	+1.2%	0.239%
2/17/2025	Voloridge Investment Management LLC	290,938	$4.05M	0.0%	+126.5%	0.249%
2/17/2025	Squarepoint Ops LLC	121,392	$1.69M	0.0%	+67.2%	0.104%
2/17/2025	Two Sigma Investments LP	84,844	$1.18M	0.0%	-51.1%	0.072%
2/17/2025	Suvretta Capital Management LLC	11,399,138	$158.79M	5.4%	+6.3%	9.740%
2/17/2025	Sherbrooke Park Advisers LLC	14,146	$0.20M	0.1%	N/A	0.012%
2/17/2025	Rafferty Asset Management LLC	210,337	$2.93M	0.0%	-24.0%	0.180%
2/17/2025	Point72 Asset Management L.P.	1,753,522	$24.43M	0.1%	+617.5%	1.498%
2/17/2025	Polar Capital Holdings Plc	7,377,381	$102.77M	0.6%	+7.2%	6.303%
2/17/2025	ProShare Advisors LLC	35,817	$0.50M	0.0%	+32.7%	0.031%
2/17/2025	Nuveen Asset Management LLC	366,886	$5.11M	0.0%	-54.6%	0.313%
2/17/2025	OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC	77,555	$1.08M	0.1%	-15.7%	0.066%
2/17/2025	Millennium Management LLC	2,310,163	$32.18M	0.0%	+101.3%	1.974%
2/17/2025	Lazard Asset Management LLC	388,313	$5.41M	0.0%	-51.7%	0.332%
2/17/2025	Lion Point Capital LP	46,300	$0.65M	3.4%	+31.9%	0.040%
2/17/2025	J. Goldman & Co LP	612,644	$8.53M	0.2%	-58.9%	0.523%
2/17/2025	Jefferies Financial Group Inc.	109,900	$1.53M	0.0%	-14.3%	0.094%
2/17/2025	Graham Capital Management L.P.	26,837	$0.37M	0.0%	+20.4%	0.023%
2/17/2025	Focus Partners Wealth	64,183	$0.89M	0.0%	N/A	0.055%
2/17/2025	Ensign Peak Advisors Inc	2,374,140	$33.07M	0.1%	-1.8%	2.028%
2/17/2025	Deutsche Bank AG	387,536	$5.40M	0.0%	-51.6%	0.331%
2/17/2025	D. E. Shaw & Co. Inc.	2,513,577	$35.01M	0.0%	+44.0%	2.148%
2/17/2025	Driehaus Capital Management LLC	1,096,769	$15.28M	0.1%	N/A	0.937%
2/17/2025	Corton Capital Inc.	15,933	$0.22M	0.1%	N/A	0.014%
2/17/2025	Cubist Systematic Strategies LLC	128,248	$1.79M	0.0%	N/A	0.110%
2/17/2025	Cercano Management LLC	1,255,365	$17.49M	0.4%	N/A	1.073%
2/17/2025	Balyasny Asset Management L.P.	103,141	$1.44M	0.0%	N/A	0.088%
2/17/2025	Bayesian Capital Management LP	17,587	$0.25M	0.0%	N/A	0.015%
2/17/2025	Bank of America Corp DE	536,458	$7.47M	0.0%	-54.4%	0.458%
2/17/2025	BNP Paribas Financial Markets	79,815	$1.11M	0.0%	N/A	0.068%
2/17/2025	Ameriprise Financial Inc.	139,929	$1.95M	0.0%	+56.8%	0.120%
2/17/2025	Algert Global LLC	80,790	$1.13M	0.0%	+11.5%	0.069%
2/14/2025	Freestone Grove Partners LP	35,818	$0.50M	0.0%	N/A	0.031%
2/14/2025	Schonfeld Strategic Advisors LLC	23,000	$0.32M	0.0%	-24.2%	0.020%
2/14/2025	Northern Trust Corp	991,056	$13.81M	0.0%	+5.8%	0.847%
2/14/2025	The Manufacturers Life Insurance Company	50,956	$0.71M	0.0%	-2.9%	0.044%
2/14/2025	Tudor Investment Corp ET AL	64,334	$0.90M	0.0%	+206.9%	0.055%
2/14/2025	Quarry LP	15,000	$0.21M	0.0%	N/A	0.013%
2/14/2025	Virtus ETF Advisers LLC	5,803	$81K	0.0%	-41.2%	0.005%
2/14/2025	Gilder Gagnon Howe & Co. LLC	3,902,991	$54.37M	0.6%	+9.8%	3.335%
2/14/2025	Voya Investment Management LLC	32,136	$0.45M	0.0%	-7.1%	0.027%
2/14/2025	Adage Capital Partners GP L.L.C.	100,000	$1.39M	0.0%	N/A	0.085%
2/14/2025	Syon Capital LLC	13,572	$0.19M	0.0%	N/A	0.012%
2/14/2025	Price T Rowe Associates Inc. MD	42,349	$0.59M	0.0%	-29.6%	0.036%
2/14/2025	Eversept Partners LP	191,158	$2.66M	0.2%	-72.4%	0.163%
2/14/2025	Hsbc Holdings PLC	17,551	$0.25M	0.0%	+36.8%	0.015%
2/14/2025	Tower Research Capital LLC TRC	14,231	$0.20M	0.0%	+62.8%	0.012%
2/14/2025	MetLife Investment Management LLC	65,471	$0.91M	0.0%	+6.2%	0.056%
2/14/2025	MYDA Advisors LLC	200,000	$2.79M	0.7%	+17.6%	0.171%
2/14/2025	First Trust Advisors LP	263,137	$3.67M	0.0%	N/A	0.225%
2/13/2025	PEAK6 LLC	20,000	$0.28M	0.0%	N/A	0.017%
2/13/2025	Jump Financial LLC	15,126	$0.21M	0.0%	N/A	0.013%
2/13/2025	Barclays PLC	237,941	$3.31M	0.0%	-6.1%	0.203%
2/13/2025	Summit Investment Advisors Inc.	11,245	$0.16M	0.1%	+8.0%	0.010%
2/13/2025	Capula Management Ltd	30,797	$0.43M	0.0%	-65.3%	0.026%
2/13/2025	Renaissance Technologies LLC	11,099	$0.16M	0.0%	-94.2%	0.009%
2/13/2025	Legal & General Group Plc	107,827	$1.50M	0.0%	-9.1%	0.092%
2/13/2025	Invesco Ltd.	1,126,668	$15.69M	0.0%	+20.1%	0.963%
2/13/2025	Federated Hermes Inc.	492,922	$6.87M	0.0%	-1.8%	0.421%
2/13/2025	Dynamic Technology Lab Private Ltd	17,603	$0.25M	0.0%	N/A	0.015%
2/13/2025	Wells Fargo & Company MN	52,455	$0.73M	0.0%	+46.6%	0.045%
2/12/2025	Trexquant Investment LP	57,658	$0.80M	0.0%	-36.1%	0.049%
2/12/2025	Geode Capital Management LLC	2,472,730	$34.45M	0.0%	+0.1%	2.113%
2/12/2025	Diametric Capital LP	20,370	$0.28M	0.2%	-38.1%	0.017%
2/12/2025	Tradewinds LLC.	14,035	$0.20M	0.1%	N/A	0.012%
2/12/2025	Franklin Resources Inc.	3,309,319	$46.10M	0.0%	-22.1%	2.828%
2/12/2025	Wellington Management Group LLP	49,267	$0.69M	0.0%	-7.3%	0.042%
2/12/2025	CIBC Private Wealth Group LLC	7,782	$0.12M	0.0%	-18.6%	0.007%
2/12/2025	Norges Bank	532,793	$7.42M	0.0%	N/A	0.455%
2/12/2025	JPMorgan Chase & Co.	1,141,505	$15.90M	0.0%	-12.0%	0.975%
2/11/2025	Prudential Financial Inc.	592,565	$8.25M	0.0%	+3.5%	0.506%
2/11/2025	Corebridge Financial Inc.	53,442	$0.74M	0.0%	-5.9%	0.046%
2/11/2025	Vanguard Group Inc.	6,440,715	$89.72M	0.0%	-7.5%	5.503%
2/11/2025	LPL Financial LLC	120,892	$1.68M	0.0%	-4.3%	0.103%
2/11/2025	Simplify Asset Management Inc.	742,299	$10.34M	0.5%	N/A	0.634%
2/11/2025	Fox Run Management L.L.C.	16,946	$0.24M	0.0%	-12.3%	0.014%
2/11/2025	KLP Kapitalforvaltning AS	24,200	$0.34M	0.0%	N/A	0.021%
2/11/2025	American Century Companies Inc.	1,631,226	$22.72M	0.0%	+11.4%	1.394%
2/11/2025	Teacher Retirement System of Texas	31,216	$0.44M	0.0%	+19.5%	0.027%
2/11/2025	Privium Fund Management B.V.	325,709	$4.54M	1.0%	N/A	0.278%
2/11/2025	Intech Investment Management LLC	42,258	$0.59M	0.0%	+13.9%	0.036%
2/10/2025	Tejara Capital Ltd	886,838	$12.35M	7.9%	-23.9%	0.758%
2/10/2025	Tocqueville Asset Management L.P.	14,200	$0.20M	0.0%	-26.0%	0.012%
2/10/2025	Cibc World Markets Corp	10,059	$0.14M	0.0%	N/A	0.009%
2/10/2025	Erste Asset Management GmbH	73,100	$1.05M	0.0%	+558.6%	0.062%
2/10/2025	Swiss National Bank	206,900	$2.88M	0.0%	+1.6%	0.177%
2/7/2025	Essex Investment Management Co. LLC	142,823	$1.99M	0.4%	-12.9%	0.122%
2/7/2025	AlphaQuest LLC	7,142	$99K	0.0%	-83.3%	0.006%
2/7/2025	PNC Financial Services Group Inc.	8,271	$0.12M	0.0%	-16.6%	0.007%
2/7/2025	Jackson Creek Investment Advisors LLC	151,293	$2.11M	0.6%	N/A	0.129%
2/7/2025	E Fund Management Co. Ltd.	14,879	$0.21M	0.0%	-16.3%	0.013%

Data available starting January 2016

See Full Table

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical ZORYVE for the treatment of scalp and body psoriasis and seborrheic dermatitis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; ARQ-255, a topical JAK1 inhibitor for alopecia areata; and ARQ-234, a CD200R fusion protein for the treatment of moderate-to-severe atopic dermatitis. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.

Today's Range

Now: $13.53

$12.79

$14.01

50 Day Range

MA: $14.34

$12.20

$17.29

52 Week Range

Now: $13.53

$6.99

$17.75

Volume

2,445,437 shs

Average Volume

2,392,177 shs

Market Capitalization

$1.61 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.67

Who are the company insiders with the largest holdings of Arcutis Biotherapeutics?: Arcutis Biotherapeutics' top insider shareholders include:
Life Sciences Viii L Frazier (Major Shareholder)
Todd Franklin Watanabe (Insider)
Patrick Burnett (Insider)
Howard G Welgus (Director)
Masaru Matsuda (Insider)
David Joseph Topper (CFO)
Larry Todd Edwards (SVP)
Larry Todd Edwards (Insider)
Terrie Curran (Director)
Learn More about top insider investors at Arcutis Biotherapeutics.
Who are the major institutional investors of Arcutis Biotherapeutics?: Arcutis Biotherapeutics' top institutional shareholders include:
Rhumbline Advisers — 0.15%
SG Americas Securities LLC — 0.03%
GAMMA Investing LLC — 0.01%
LVW Advisors LLC — 0.01%
Learn More about top institutional investors of Arcutis Biotherapeutics stock.
Which institutional investors are selling Arcutis Biotherapeutics stock?: During the previous quarter, ARQT stock was sold by these institutional investors:
SG Americas Securities LLC
In the last year, company insiders that have sold Arcutis Biotherapeutics company stock include:
Life Sciences Viii L Frazier (Major Shareholder)
Todd Franklin Watanabe (Insider)
Patrick Burnett (Insider)
Howard G Welgus (Director)
Masaru Matsuda (Insider)
David Joseph Topper (CFO)
Larry Todd Edwards (SVP)
Learn More investors selling Arcutis Biotherapeutics stock.
Which institutional investors are buying Arcutis Biotherapeutics stock?: During the previous quarter, ARQT stock was purchased by institutional investors including:
GAMMA Investing LLC
Rhumbline Advisers
LVW Advisors LLC
Within the last year, these company insiders have bought Arcutis Biotherapeutics stock:
Life Sciences Viii L Frazier (Major Shareholder)
Todd Franklin Watanabe (Insider)
Learn More investors buying Arcutis Biotherapeutics stock.